149 related articles for article (PubMed ID: 21803969)
1. Rimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Gα i/o inhibition.
Wu HM; Yang YM; Kim SG
Mol Pharmacol; 2011 Nov; 80(5):859-69. PubMed ID: 21803969
[TBL] [Abstract][Full Text] [Related]
2. Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation.
Han CY; Ki SH; Kim YW; Noh K; Lee DY; Kang B; Ryu JH; Jeon R; Kim EH; Hwang SJ; Kim SG
Antioxid Redox Signal; 2011 Jan; 14(2):187-202. PubMed ID: 20560786
[TBL] [Abstract][Full Text] [Related]
3. Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones.
Hwahng SH; Ki SH; Bae EJ; Kim HE; Kim SG
Hepatology; 2009 Jun; 49(6):1913-25. PubMed ID: 19378344
[TBL] [Abstract][Full Text] [Related]
4. Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-α-induced hepatic lipogenesis through AMP-activated protein kinase activation.
Choi du G; Kim EK; Yang JW; Song JS; Kim YM
Pharmazie; 2015 Nov; 70(11):733-9. PubMed ID: 26790190
[TBL] [Abstract][Full Text] [Related]
5. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver.
Yamamoto T; Shimano H; Inoue N; Nakagawa Y; Matsuzaka T; Takahashi A; Yahagi N; Sone H; Suzuki H; Toyoshima H; Yamada N
J Biol Chem; 2007 Apr; 282(16):11687-95. PubMed ID: 17296605
[TBL] [Abstract][Full Text] [Related]
7. Cynandione A from Cynanchum wilfordii inhibits hepatic de novo lipogenesis by activating the LKB1/AMPK pathway in HepG2 cells.
Kim S; Yoon YY; Park YW; Whang WK; Park SY; Hwang KW
J Nat Med; 2020 Jan; 74(1):142-152. PubMed ID: 31463669
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
Jin SH; Yang JH; Shin BY; Seo K; Shin SM; Cho IJ; Ki SH
Toxicol Appl Pharmacol; 2013 Aug; 271(1):95-105. PubMed ID: 23651738
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis.
Kim EJ; Yoon YS; Hong S; Son HY; Na TY; Lee MH; Kang HJ; Park J; Cho WJ; Kim SG; Koo SH; Park HG; Lee MO
Hepatology; 2012 May; 55(5):1379-88. PubMed ID: 22183856
[TBL] [Abstract][Full Text] [Related]
10. Oleanolic Acid Inhibits Liver X Receptor Alpha and Pregnane X Receptor to Attenuate Ligand-Induced Lipogenesis.
Lin YN; Chang HY; Wang CCN; Chu FY; Shen HY; Chen CJ; Lim YP
J Agric Food Chem; 2018 Oct; 66(42):10964-10976. PubMed ID: 30351048
[TBL] [Abstract][Full Text] [Related]
11. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis.
Kim YW; Kim YM; Yang YM; Kim TH; Hwang SJ; Lee JR; Kim SC; Kim SG
Free Radic Biol Med; 2010 Feb; 48(4):567-78. PubMed ID: 20005944
[TBL] [Abstract][Full Text] [Related]
13. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW
Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089
[TBL] [Abstract][Full Text] [Related]
14. 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway.
Pil Hwang Y; Gyun Kim H; Choi JH; Truong Do M; Tran TP; Chun HK; Chung YC; Jeong TC; Jeong HG
Mol Nutr Food Res; 2013 Mar; 57(3):471-82. PubMed ID: 23349077
[TBL] [Abstract][Full Text] [Related]
15. Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation.
Yoon YS; Seo WY; Lee MW; Kim ST; Koo SH
J Biol Chem; 2009 Apr; 284(16):10446-52. PubMed ID: 19244231
[TBL] [Abstract][Full Text] [Related]
16. Phillyrin attenuates high glucose-induced lipid accumulation in human HepG2 hepatocytes through the activation of LKB1/AMP-activated protein kinase-dependent signalling.
Do MT; Kim HG; Choi JH; Khanal T; Park BH; Tran TP; Hwang YP; Na M; Jeong HG
Food Chem; 2013 Jan; 136(2):415-25. PubMed ID: 23122079
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid CB
Chen W; Liu H; Guan H; Xue N; Wang L
Eur J Pharmacol; 2017 Nov; 814():232-239. PubMed ID: 28844874
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition.
Kim YM; Kim TH; Kim YW; Yang YM; Ryu DH; Hwang SJ; Lee JR; Kim SC; Kim SG
Free Radic Biol Med; 2010 Dec; 49(11):1722-34. PubMed ID: 20840863
[TBL] [Abstract][Full Text] [Related]
19. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain.
Erdozain AM; Diez-Alarcia R; Meana JJ; Callado LF
Biochem Pharmacol; 2012 Jan; 83(2):260-8. PubMed ID: 22093909
[TBL] [Abstract][Full Text] [Related]
20. An active metabolite of oltipraz (M2) increases mitochondrial fuel oxidation and inhibits lipogenesis in the liver by dually activating AMPK.
Kim TH; Eom JS; Lee CG; Yang YM; Lee YS; Kim SG
Br J Pharmacol; 2013 Apr; 168(7):1647-61. PubMed ID: 23145499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
